The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 17 results:
Author Title [ Type(Desc)] Year
Filters: Author is Anagnostopoulos, Achilles  [Clear All Filters]
Journal Article
Papadopoulou, A., Alvanou M., Koukoulias K., Athanasiou E., Lazaridou A., Savvopoulos N., et al. (2019).  Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.. Bone Marrow Transplant. 54(12), 1963-1972.
Papadopoulou, A., Alvanou M., Koukoulias K., Athanasiou E., Lazaridou A., Savvopoulos N., et al. (2019).  Correction to: Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.. Bone Marrow Transplant. 54(12), 2120.
Tsingotjidou, A. S., Emmanouilides C. E., Siotou E., Poutahidis T., Xagorari A., Loukopoulos P., et al. (2009).  Establishment of an animal model for Waldenström's macroglobulinemia.. Exp Hematol. 37(4), 469-76.
Gavriilaki, E., Mainou M., Christodoulou I., Koravou E-E., Paleta A., Touloumenidou T., et al. (2017).   evidence of complement activation in patients with sickle cell disease.. Haematologica. 102(12), e481-e482.
Gavriilaki, E., Asteris P. G., Touloumenidou T., Koravou E-E., Koutra M., Papayanni P. Georgia, et al. (2021).  Genetic justification of severe COVID-19 using a rigorous algorithm.. Clin Immunol. 226, 108726.
Asteris, P. G., Gavriilaki E., Touloumenidou T., Koravou E-E., Koutra M., Papayanni P. Georgia, et al. (2022).  Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks.. J Cell Mol Med. 26(5), 1445-1455.
Varelas, C., Gavriilaki E., Sakellari I., Klonizakis F., Anagnostopoulos A., Tsapas A., et al. (2022).  Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.. Hemoglobin. 46(2), 143-145.
Samalidou, M., Bougiouklis D., Vyzantiadis T-A., Meletiadis J., Monokrousos N., Siotou E., et al. (2015).  In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice.. Exp Biol Med (Maywood). 240(12), 1728-34.
Katodritou, E., Terpos E., Kastritis E., Delimpasis S., Symeonidis A. S., Repousis P., et al. (2015).  Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.. Ann Hematol. 94(12), 2033-42.
Gavriilaki, M., Mainou M., Gavriilaki E., Haidich A-B., Papagiannopoulos S., Sakellari I., et al. (2019).  Neurologic complications after allogeneic transplantation: a meta-analysis.. Ann Clin Transl Neurol. 6(10), 2037-2047.
Sakellari, I., Gavriilaki E., Papagiannopoulos S., Gavriilaki M., Batsis I., Mallouri D., et al. (2019).  Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality.. J Neurol. 266(8), 1960-1972.
Gavriilaki, E., Christodoulou I., Koravou E-E., Paleta A., Koutra M., Zerva P., et al. (2018).  Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia.. Hemasphere. 2(5), e58.
Katodritou, E., Kyrtsonis M-C., Delimpasi S., Kyriakou D., Symeonidis A., Spanoudakis E., et al. (2018).  Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.. Ann Hematol. 97(9), 1671-1682.
Katodritou, E., Terpos E., Delimpasi S., Kotsopoulou M., Michalis E., Vadikolia C., et al. (2018).  Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.. Blood Cancer J. 8(3), 31.
Gavriilidis, G. I., Ntoufa S., Papakonstantinou N., Kotta K., Koletsa T., Chartomatsidou E., et al. (2020).  Stem cell factor Is implicated In microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia.. Haematologica.
Vlachaki, E., Gavriilaki E., Kafantari K., Adamidou D., Tsitsikas D., Chasapopoulou E., et al. (2018).  Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.. Hemoglobin. 42(5-6), 339-341.
Gavriilaki, E., Tsiftsoglou S. A., Touloumenidou T., Farmaki E., Panagopoulou P., Michailidou E., et al. (2022).  Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection.. Curr Issues Mol Biol. 44(7), 2811-2824.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.